Knowing the demerits of the transrectal ultrasound guided biopsy has led to a shift in the general techniques and technology of the prostate biopsy. In addition, the advances in magnetic resonance imaging (MRI) sensitivity and the evidence from the PROMIS trial about its ability to detect clinically significant tumours encourage urologists and industry to implement MRI-guided targeted biopsy. However, the science is still looking how to improve safety and increase its cancer detection rate (CDR).
Keywords: Prostate cancer; biopsy; grade; magnetic resonance imaging (MRI); prostate neoplasm.
2020 Translational Andrology and Urology. All rights reserved.